Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer. (Q33468213)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer. |
scientific article |
Statements
Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer (English)
C G Moertel
A J Schutt
R J Reitemeier
1 February 1972